ClinicalTrials.gg
Not yet recruitingNCT07486973LayLedCBTIGUpdated Mar 23, 2026

Lay-led Brief Cognitive Behavioural Therapy for Insomnia (CBT-I) Group for Older Adults in Hong Kong: A Pilot Study

An interventional study of Lay-led CBT-I brief group and Booklet on sleep health in Sleep Quality, sponsored by The University of Hong Kong. Not yet recruiting at 1 site in Hong Kong. Open to participants aged 45 Years and older. Per ClinicalTrials.gov, last updated 2026-03-23.

Sponsored by The University of Hong Kong · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Non-randomized
Ages
45 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to study whether a Cognitive Behavioural Therapy for Insomnia (CBT-I) group led by laypersons serves as an effective tool for alleviating insomnia in older Chinese adults in Hong Kong. The main questions it aims to answer are: 1) Can the group improve subjective sleep quality? 2) What is the feasibility and acceptability of the group? Researchers will compare the intervention group with a control group. Participants will either join the intervention group or receive a self-help booklet, depending on their assignment. Both groups will complete two questionnaires over a four-week period: Baseline and Week-4 data.

02

Conditions studied

  • Sleep Quality

Keywords

  • Cognitive Behavioural Therapy for Insomnia
  • Task-shifting
  • Sleep hygiene
  • Stimulus control
  • Sleep health
  • Lay-led psychotherapy
  • lay-led psychotherapy group
  • Subjective sleep quality
  • Cognitive restructuring
03

In context

Sleep Initiation and Maintenance Disorders

2,722 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 726 are open to participants now.

This study's planned enrollment of 50 is below the median of 68 across 2,350 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

The University of Hong Kong is the lead sponsor of 1,292 studies on the registry; 348 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 45 or older
  • Have a PHQ-9 score between 5-9, and item 3 must be scored at 2 or higher
  • Experiencing existing symptoms of depression and sleep disturbance
  • Capable of providing for their participation in the study

Exclusion criteria

Exclusion Criteria:

  • Known history of intellectual disabilities, schizophrenia spectrum disorders, bipolar disorder, Parkinson's disease, or dementia
  • Assessed to be at active suicidal risk
  • Significant difficulties in communication
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Active comparator
    The control group (CG)

    Participants will receive a booklet on sleep hygiene education and will be asked to follow the instruction for 4 weeks for the same duration as the intervention group.

    Behavioral: Booklet on sleep health

  • Experimental
    The emotional support assistant group (ESAG)

    A brief in-person group for CBT-I, consisting of four sessions, with each session lasting approximately 1.5 hours and expected to be completed within a month. The sessions will cover four treatment components: sleep hygiene, stimulus control, cognitive restructuring, and relaxation exercises, all facilitated by trained Emotional Support Assistants.

    Behavioral: Lay-led CBT-I brief group

Interventions

  • BehavioralLay-led CBT-I brief group

    Participants will participate in a brief in-person group for CBT-I, consisting of four sessions, with each session lasting approximately 1.5 hours and expected to be completed within a month. The sessions will cover four treatment components: sleep hygiene, stimulus control, cognitive restructuring, and relaxation exercises, all facilitated by trained Emotional Support Assistants.

  • BehavioralBooklet on sleep health

    Eligible control group participants will receive a booklet on sleep hygiene education.

06

What researchers measure

Primary outcomes

  1. Subjective sleep quality

    Brief Version of the Pittsburgh Sleep Quality Index (B-PSQI): Likert scale with a global scoring ranging from 0 to 15. A higher score indicates worse sleep quality.

    Time frame: From first session to last session at 4 weeks.

Secondary outcomes

  1. Dysfunctional Beliefs and Attitudes about Sleep

    A 16-items scale ranging from 0 (Strongly Disagree) to 10 (Strongly Agree). Stronger endorsement of these beliefs indicates greater maladaptation in detecting therapeutic changes and effectiveness.

    Time frame: From first session to last session at 4 weeks.

  2. Pre-sleep Arousal Scale

    Rated on a 5-point Likert scale, ranging from 1 (Not at all) to 5 (Extremely), with total scores ranging from 8 to 40 for both subscales. Higher scores indicate an increased level of pre-sleep arousal.

    Time frame: From first session to last session at 4 weeks.

07

Study locations

1 site
08

References and documents

Publications

  • Frishammar, J., Essén, A., Bergström, F., & Ekman, T. (2023). Digital health platforms for the elderly? Key adoption and usage barriers and ways to address them. Technological Forecasting and Social Change, 189, 122319. https://doi.org/10.1016/j.techfore.2023.122319
  • Julious, S. A. (2005). Sample size of 12 per group rule of thumb for a pilot study. Pharmaceutical Statistics, 4(4), 287-291. https://doi.org/10.1002/pst.185
  • Wing, Y. K., CHAN, N. Y. R., Xie, C., Chen, S., Yu, D., & Chan, J. W. Y. (2024). Determinants of help-seeking behaviors for insomnia in Hong Kong Chinese: Community-based survey. Journal of Sleep Research, 33(S1), 503-504. https://doi.org/10.1111/jsr.14291
  • World Health Organization, PEPFAR & UNAIDS (2007). Task shifting : rational redistribution of tasks among health workforce teams : global recommendations and guidelines. World Health Organization. https://iris.who.int/handle/10665/43821
  • Yeung WF, Lai AY, Yu BY, Ho FY, Chung KF, Ho JY, Suen LK, Ho LM, Lam TH. Effect of zero-time exercise on physically inactive adults with insomnia disorder: A randomized controlled trial. Int J Nurs Stud. 2025 May;165:105033. doi: 10.1016/j.ijnurstu.2025.105033. Epub 2025 Feb 18. PubMed 39999728 ↗
  • Yeung WF, Yu BY, Chung KF, Zhang ZJ, Lao L, Ho FY, Suen LK, Ho LM. Self-administered acupressure for insomnia disorder: A randomized controlled trial. Phytomedicine. 2022 May;99:153993. doi: 10.1016/j.phymed.2022.153993. Epub 2022 Feb 15. PubMed 35193046 ↗
  • Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Ann Intern Med. 2015 Aug 4;163(3):191-204. doi: 10.7326/M14-2841. PubMed 26054060 ↗
  • Sweetman A, McEvoy RD, Frommer MS, Adams R, Chai-Coetzer CL, Newell S, Moxham-Hall V, Redman S. Promoting sustained access to cognitive behavioral therapy for insomnia in Australia: a system-level implementation program. J Clin Sleep Med. 2025 Feb 1;21(2):325-335. doi: 10.5664/jcsm.11374. PubMed 39364910 ↗
  • Steinmetz L, Simon L, Feige B, Riemann D, Johann AF, Ell J, Ebert DD, Baumeister H, Benz F, Spiegelhalder K. Network meta-analysis examining efficacy of components of cognitive behavioural therapy for insomnia. Clin Psychol Rev. 2024 Dec;114:102507. doi: 10.1016/j.cpr.2024.102507. Epub 2024 Oct 28. PubMed 39504928 ↗
  • Stanley MA, Wilson NL, Amspoker AB, Kraus-Schuman C, Wagener PD, Calleo JS, Cully JA, Teng E, Rhoades HM, Williams S, Masozera N, Horsfield M, Kunik ME. Lay providers can deliver effective cognitive behavior therapy for older adults with generalized anxiety disorder: a randomized trial. Depress Anxiety. 2014 May;31(5):391-401. doi: 10.1002/da.22239. Epub 2014 Feb 27. PubMed 24577847 ↗
  • Simon L, Steinmetz L, Berghoff N, Rehm C, Neumann LM, Kuchler AM, Riemann D, Ebert DD, Spiegelhalder K, Baumeister H. Barriers and Facilitators of Sleep Restriction Therapy in Internet-Delivered CBT-I: A Qualitative Content Analysis and the Development of a Treatment Path Model. J Sleep Res. 2025 Dec;34(6):e70018. doi: 10.1111/jsr.70018. Epub 2025 Feb 24. PubMed 39994983 ↗
  • Shorey S, Chua JYX. Effectiveness of peer support interventions for adults with depressive symptoms: a systematic review and meta-analysis. J Ment Health. 2023 Apr;32(2):465-479. doi: 10.1080/09638237.2021.2022630. Epub 2022 Jan 7. PubMed 34994272 ↗
  • Sancho-Domingo C, Carballo JL, Coloma-Carmona A, Buysse DJ. Brief version of the Pittsburgh Sleep Quality Index (B-PSQI) and measurement invariance across gender and age in a population-based sample. Psychol Assess. 2021 Feb;33(2):111-121. doi: 10.1037/pas0000959. Epub 2020 Oct 29. PubMed 33119375 ↗
  • Puzino K, Amatrudo G, Sullivan A, Vgontzas AN, Fernandez-Mendoza J. Clinical Significance and Cut-Off Scores for the Pre-Sleep Arousal Scale in Chronic Insomnia Disorder: A Replication in a Clinical Sample. Behav Sleep Med. 2020 Nov-Dec;18(6):705-718. doi: 10.1080/15402002.2019.1669604. Epub 2019 Sep 23. PubMed 31545084 ↗
  • Nicassio PM, Mendlowitz DR, Fussell JJ, Petras L. The phenomenology of the pre-sleep state: the development of the pre-sleep arousal scale. Behav Res Ther. 1985;23(3):263-71. doi: 10.1016/0005-7967(85)90004-x. No abstract available. PubMed 4004706 ↗
  • Morin CM, Vallieres A, Ivers H. Dysfunctional beliefs and attitudes about sleep (DBAS): validation of a brief version (DBAS-16). Sleep. 2007 Nov;30(11):1547-54. doi: 10.1093/sleep/30.11.1547. PubMed 18041487 ↗
  • Meaklim H, Farrough J, Staben K, Morillo Aguirre AV, Jackson ML, Meltzer LJ, Junge MF, Kennedy GA, Bucks RS, Sweetman A, Phillips LJ, Cunnington DC, Lyons KM, Graco M, Rehm IC. A Qualitative Exploration of Barriers and Facilitators to Implementing Sleep and Cognitive Behavioral Therapy for Insomnia Knowledge Into Graduate Psychology Students' Practice. Behav Sleep Med. 2026 Mar-Apr;24(2):200-218. doi: 10.1080/15402002.2025.2576909. Epub 2025 Oct 30. PubMed 41163515 ↗
  • Lu L, Wang SB, Rao W, Zhang Q, Ungvari GS, Ng CH, Kou C, Jia FJ, Xiang YT. The Prevalence of Sleep Disturbances and Sleep Quality in Older Chinese Adults: A Comprehensive Meta-Analysis. Behav Sleep Med. 2019 Nov-Dec;17(6):683-697. doi: 10.1080/15402002.2018.1469492. Epub 2018 May 31. PubMed 29851516 ↗
  • Li M, Wang N, Dupre ME. Association between the self-reported duration and quality of sleep and cognitive function among middle-aged and older adults in China. J Affect Disord. 2022 May 1;304:20-27. doi: 10.1016/j.jad.2022.02.039. Epub 2022 Feb 14. PubMed 35176346 ↗
  • Lee S, Kim JH, Chung JH. The association between sleep quality and quality of life: a population-based study. Sleep Med. 2021 Aug;84:121-126. doi: 10.1016/j.sleep.2021.05.022. Epub 2021 May 27. PubMed 34147026 ↗
  • Lai VKY, Fung AWT, Lam LCW, Lee ATC. Is sleep quality a potential predictor of neurocognitive disorders? A 6-year follow-up study in Chinese older adults. Int J Geriatr Psychiatry. 2022 Aug;37(8). doi: 10.1002/gps.5783. PubMed 35844091 ↗
  • Hrozanova M, Skarpsno ES, Follestad T, Kallestad H, Pallesen S, Nordstoga AL, Mollerlokken NE, Ronning AS, Meisingset I. Effectiveness of group-delivered cognitive behavioural therapy for insomnia in primary care: a pragmatic, multicentre randomised controlled trial. Sleep Med. 2025 Jul;131:106495. doi: 10.1016/j.sleep.2025.106495. Epub 2025 Apr 2. PubMed 40220528 ↗
  • Edinger JD, Arnedt JT, Bertisch SM, Carney CE, Harrington JJ, Lichstein KL, Sateia MJ, Troxel WM, Zhou ES, Kazmi U, Heald JL, Martin JL. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021 Feb 1;17(2):255-262. doi: 10.5664/jcsm.8986. PubMed 33164742 ↗
  • Del Brutto OH, Mera RM, Rumbea DA, Sedler MJ, Castillo PR. Poor sleep quality increases mortality risk: A population-based longitudinal prospective study in community-dwelling middle-aged and older adults. Sleep Health. 2024 Feb;10(1):144-148. doi: 10.1016/j.sleh.2023.10.009. Epub 2023 Nov 25. PubMed 38007301 ↗
  • Davidson JR, Dawson S, Krsmanovic A. Effectiveness of Group Cognitive Behavioral Therapy for Insomnia (CBT-I) in a Primary Care Setting. Behav Sleep Med. 2019 Mar-Apr;17(2):191-201. doi: 10.1080/15402002.2017.1318753. Epub 2017 May 2. PubMed 28463015 ↗
  • Crowley K. Sleep and sleep disorders in older adults. Neuropsychol Rev. 2011 Mar;21(1):41-53. doi: 10.1007/s11065-010-9154-6. Epub 2011 Jan 12. PubMed 21225347 ↗
  • Chien MY, Chen HC. Poor sleep quality is independently associated with physical disability in older adults. J Clin Sleep Med. 2015 Mar 15;11(3):225-32. doi: 10.5664/jcsm.4532. PubMed 25515275 ↗
  • Cheung JMY, Jarrin DC, Ballot O, Bharwani AA, Morin CM. A systematic review of cognitive behavioral therapy for insomnia implemented in primary care and community settings. Sleep Med Rev. 2019 Apr;44:23-36. doi: 10.1016/j.smrv.2018.11.001. Epub 2018 Nov 23. PubMed 30612061 ↗
  • Chen SJ, Que JY, Chan NY, Shi L, Li SX, Chan JWY, Huang W, Chen CX, Tsang CC, Ho YL, Morin CM, Zhang JH, Lu L, Wing YK. Effectiveness of app-based cognitive behavioral therapy for insomnia on preventing major depressive disorder in youth with insomnia and subclinical depression: A randomized clinical trial. PLoS Med. 2025 Jan 21;22(1):e1004510. doi: 10.1371/journal.pmed.1004510. eCollection 2025 Jan. PubMed 39836656 ↗
  • Browne RH. On the use of a pilot sample for sample size determination. Stat Med. 1995 Sep 15;14(17):1933-40. doi: 10.1002/sim.4780141709. PubMed 8532986 ↗
  • Becker NB, Jesus SN, Joao KADR, Viseu JN, Martins RIS. Depression and sleep quality in older adults: a meta-analysis. Psychol Health Med. 2017 Sep;22(8):889-895. doi: 10.1080/13548506.2016.1274042. Epub 2016 Dec 26. PubMed 28013552 ↗
  • Alimoradi Z, Jafari E, Brostrom A, Ohayon MM, Lin CY, Griffiths MD, Blom K, Jernelov S, Kaldo V, Pakpour AH. Effects of cognitive behavioral therapy for insomnia (CBT-I) on quality of life: A systematic review and meta-analysis. Sleep Med Rev. 2022 Aug;64:101646. doi: 10.1016/j.smrv.2022.101646. Epub 2022 May 10. PubMed 35653951 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2026; primary completion for Jun 2027, 15 months later.

Of 1,207 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 15 months is close to that.

Counting every sponsor, half of 1,285 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 17, 2026
First posted
Mar 23, 2026
StartEst.
Mar 2026
Primary completionEst.
Jun 2027
CompletionEst.
Dec 2027
Last update
Mar 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07486973
Responsible party
YU Yee Man Branda (Research Assistant Professor, The University of Hong Kong) — Principal investigator
First posted
Mar 23, 2026
Start date
Mar 2026 (estimated)
Primary completion
Jun 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Mar 23, 2026

Study contacts

Yee Man Branda YU
Contact
branda.yu@hku.hk
+852 39173914
Long Ni WONG
Contact
lonniw@hku.hk
+852 39173913

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion